Latest / New Retina Radio by Eyetube
DME, DR, and Next-Generation Therapies
How should retina specialists integrate next-generation anti-VEGF agents into real-world DME care? In this episode of “Anti-VEGFs: The Next Generation,” David Miller, MD, speaks with Esther Kim, MD, and Ehsan Rahimy, MD, about first-line agent selection, when to transition to newer options, how to incorporate steroids thoughtfully, and crafting dosing strategies that balance durability, efficacy, and adherence for working-age patients—without overpromising outcomes.
This editorially independent series is supported with advertising by Regeneron.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.